Company: DRTSW
Filing Date: 2025-03-12
Form Type: 20-F
Source: 0001213900-25-023187
Chunk: 69

Company: Alpha Tau Medical Ltd.
Filing Date: 2025-03-12
Form: 20-F
Item: Item 3
Chunk 69
---
 patent
agencies, and our patent protection could be reduced or eliminated for non-compliance with these requirements.

Periodic maintenance fees
on any issued patent are due to be paid to the USPTO and foreign countries may require the payment of maintenance fees or patent annuities
during the lifetime of a patent application and/or any subsequent patent that issues from the application. The USPTO and various foreign
governmental patent agencies require compliance with a number of procedural, documentary, fee payment and other similar provisions during
the patent application process and following the issuance of a patent. While an inadvertent lapse can in many cases be cured by payment
of a late fee or by other means in accordance with the applicable rules, there are situations in which noncompliance can result in abandonment
or lapse of the patent or patent application. Such noncompliance can result in partial or complete loss of patent rights in the relevant
jurisdiction. Noncompliance events that could result in abandonment or lapse of a patent or patent application include, but are not limited
to, failure to respond to official actions within prescribed time limits, non-payment of fees and failure to properly legalize and submit
formal documents. Such an event could have a material adverse effect on our business.

Any issued patents we own covering our product
candidates could be narrowed or found invalid or unenforceable if challenged in court or before the administrative bodies in the United
States or abroad, including the USPTO.

Any of our intellectual property
rights could be challenged or invalidated despite measures we take to obtain patent and other intellectual property protection with respect
to our product candidates and proprietary technology. For example, if we initiate legal proceedings against a third party to enforce a
patent covering one of our product candidates, the defendant could counterclaim that the patent covering our product candidate, as applicable,
is invalid and/or unenforceable. In patent litigation in the United States and in some other jurisdictions, defendant counterclaims alleging
invalidity and/or unenforceability are commonplace, and there are numerous grounds upon which a third party can assert invalidity or unenforceability
of a patent. Grounds for a validity challenge could be an alleged failure to meet any of several statutory requirements, for example,
lack of novelty, obviousness or non-enablement. Grounds for an unenforceability assertion could be an allegation that someone connected
with prosecution of the patent withheld material information from the USPTO or the applicable foreign counterpart, or made a misleading